173 related articles for article (PubMed ID: 35917101)
1. Pinocembrin Relieves Mycoplasma pneumoniae Infection‑Induced Pneumonia in Mice Through the Inhibition of Oxidative Stress and Inflammatory Response.
Qian J; Xue M
Appl Biochem Biotechnol; 2022 Dec; 194(12):6335-6348. PubMed ID: 35917101
[TBL] [Abstract][Full Text] [Related]
2. Geraniol relieves mycoplasma pneumonia infection-induced lung injury in mice through the regulation of ERK/JNK and NF-κB signaling pathways.
Fu YS; Duan XQ; Cheng KR; Yan-Yan-Fei ; Liu L; Duan HD; Hu Q; Xia SL; Wang XR; Cheng ZF
J Biochem Mol Toxicol; 2022 Apr; 36(4):e22984. PubMed ID: 35038199
[TBL] [Abstract][Full Text] [Related]
3. Baicalin relieves
Zhang H; Li X; Wang J; Cheng Q; Shang Y; Wang G
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109422
[No Abstract] [Full Text] [Related]
4. Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.
Fonseca-Aten M; Salvatore CM; Mejías A; Ríos AM; Chávez-Bueno S; Katz K; Gómez AM; McCracken GH; Hardy RD
Antimicrob Agents Chemother; 2005 Oct; 49(10):4128-36. PubMed ID: 16189089
[TBL] [Abstract][Full Text] [Related]
5. Ameliorative effects of Qingfei Tongluo formula on experimental mycoplasmal pneumonia in mice.
Jiang YH; Yu JE; Guo AH; Li X; Lin Y; Jiang ZY; Xiao Z
J Nat Med; 2016 Apr; 70(2):145-51. PubMed ID: 26590157
[TBL] [Abstract][Full Text] [Related]
6. Intranasal interleukin-12 therapy inhibits Mycoplasma pneumoniae clearance and sustains airway obstruction in murine pneumonia.
Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Hardy RD
Infect Immun; 2008 Feb; 76(2):732-8. PubMed ID: 18039833
[TBL] [Abstract][Full Text] [Related]
7. Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.
Salvatore CM; Fonseca-Aten M; Katz-Gaynor K; Gomez AM; Mejias A; Somers C; Chavez-Bueno S; McCracken GH; Hardy RD
Infect Immun; 2007 Jan; 75(1):236-42. PubMed ID: 17074851
[TBL] [Abstract][Full Text] [Related]
8. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effect of Albizia chinensis synthesized ZnO-NPs on Mycoplasma pneumoniae infected pneumonia mice model.
Yu L; Lu M; Zhang W; Alarfaj AA; Hirad AH; Zhang H
Microb Pathog; 2020 Apr; 141():103960. PubMed ID: 31953224
[TBL] [Abstract][Full Text] [Related]
10. Pinocembrin attenuates allergic airway inflammation via inhibition of NF-κB pathway in mice.
Gu X; Zhang Q; Du Q; Shen H; Zhu Z
Int Immunopharmacol; 2017 Dec; 53():90-95. PubMed ID: 29055190
[TBL] [Abstract][Full Text] [Related]
11. Morusin alleviates mycoplasma pneumonia via the inhibition of Wnt/β-catenin and NF-κB signaling.
Chen C; Wang J; Chen J; Zhou L; Wang H; Chen J; Xu Z; Zhu S; Liu W; Yu R; Lu J; Luo H; Chen M; Chen W
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31171712
[TBL] [Abstract][Full Text] [Related]
12. Analysis of cytokine levels, cytological findings, and MP-DNA level in bronchoalveolar lavage fluid of children with Mycoplasma pneumoniae pneumonia.
Deng F; Cao H; Liang X; Li Q; Yang Y; Zhao Z; Tan J; Fu G; Shu C
Immun Inflamm Dis; 2023 May; 11(5):e849. PubMed ID: 37249293
[TBL] [Abstract][Full Text] [Related]
13. S-allylmercaptocysteine ameliorates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation and oxidative stress via nuclear factor kappa B and Keap1/Nrf2 pathways.
Mo M; Li S; Dong Z; Li C; Sun Y; Li A; Zhao Z
Int Immunopharmacol; 2020 Apr; 81():106273. PubMed ID: 32070920
[TBL] [Abstract][Full Text] [Related]
14. Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.
Salvatore CM; Techasaensiri C; Tagliabue C; Katz K; Leos N; Gomez AM; McCracken GH; Hardy RD
Antimicrob Agents Chemother; 2009 Apr; 53(4):1546-51. PubMed ID: 19139287
[TBL] [Abstract][Full Text] [Related]
15. Protective anti-inflammatory activity of tovophyllin A against acute lung injury and its potential cytotoxicity to epithelial lung and breast carcinomas.
El-Agamy DS; Mohamed GA; Ahmed N; Elkablawy MA; Elfaky MA; Elsaed WM; Mohamed SGA; Ibrahim SRM
Inflammopharmacology; 2020 Feb; 28(1):153-163. PubMed ID: 31218570
[TBL] [Abstract][Full Text] [Related]
16. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
17. Modulatory apoptotic effects of sinomenine on Mycoplasma pneumonia through the attenuation of inflammation via ERK/JNK/NF-κB signaling pathway.
Chen Y; Zhang W; Xin L; Wang Z; Zheng M; Vijayalakshmi A
Arch Microbiol; 2022 Jun; 204(7):441. PubMed ID: 35773566
[TBL] [Abstract][Full Text] [Related]
18. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease.
Hardy RD; Jafri HS; Olsen K; Hatfield J; Iglehart J; Rogers BB; Patel P; Cassell G; McCracken GH; Ramilo O
Infect Immun; 2002 Feb; 70(2):649-54. PubMed ID: 11796594
[TBL] [Abstract][Full Text] [Related]
19. Atopy: a risk factor of refractory mycoplasma pneumoniae pneumonia?
Bao YX; Li J; Tian Y; Liu QH; Bao J
Clin Respir J; 2017 Nov; 11(6):931-934. PubMed ID: 26683420
[TBL] [Abstract][Full Text] [Related]
20. Toll-Like Receptor 2 Modulates Pulmonary Inflammation and TNF-α Release Mediated by
Chen M; Deng H; Zhao Y; Miao X; Gu H; Bi Y; Zhu Y; Guo Y; Shi S; Xu J; Zhao D; Liu F
Front Cell Infect Microbiol; 2022; 12():824027. PubMed ID: 35372108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
